Paying For Personalized Medicine: Medicare CED Approach Advised
This article was originally published in The Gray Sheet
Executive Summary
If CMS proceeds with a national coverage determination on diagnostics for patient-specific drug therapy, it should consider a Coverage with Evidence Development approach, the Personalized Medicine Coalition suggests in Sept. 26 comments to the agency
You may also be interested in...
Dear Daschle: HHS Advisors Draft Personalized Medicine Priorities For 2009
The Health and Human Services advisory committee dedicated to genetic tests and technologies will push personalized medicine as a central part of health care reform under the new administration
Dear Daschle: HHS Advisors Draft Personalized Medicine Priorities For 2009
Reimbursement reforms for companion diagnostics high on the list.
Dear Daschle: HHS Advisors Draft Personalized Medicine Priorities For 2009
The Health and Human Services advisory committee dedicated to genetic tests and technologies will push personalized medicine as a central part of health care reform under the new administration